W. Lin et al.
Synthesis of compound 1: Compound 2 (45.0 mg, 0.06 mmol), N-hydroxy-
succinimide (21.0 mg, 0.18 mmol), and DCC (37.1 mg, 0.18 mmol) were
dissolved in CH2Cl2 (5.0 mL) with stirring at room temperature. After
30 min, triethylamine (0.05 mL) and 4-mercaptophenol (11.5 mg,
0.09 mmol) were added. The reaction solution was stirred for another
30 min at room temperature, and the mixture was then concentrated
under vacuum. The resulting residue was subjected to preparative thin-
layer chromatography (CH2Cl2/CH3OH=5:1) to provide compound 1 as
a carmine powder (31.5 mg, 61.0% yield). 1H NMR (CD3OD, 500 MHz):
27, 1145; f) S. Khatib, R. Musaa, J. Vaya, Bioorg. Med. Chem. 2007,
15, 3.
[3] For a review, see: X. Chen, Y. Zhou, X. Peng, J. Yoon, Chem. Soc.
[4] For some recent examples, see: a) M. Zhang, M. Yu, F. Li, M. Zhu,
M. Li, Y. Gao, L. Li, Z. Liu, J. Zhang, D. Zhang, T. Yi, C. Huang, J.
han, S. Kim, S. W. Lee, J. L. Sessler, T. W. Kim, C. Kang, J. S. Kim,
e) H.-Y. Shiu, H.-C. Chong, Y.-C. Leung, M.-K. Wong, C.-M. Che,
j) Z. Yang, N. Zhao, Y. Sun, F. Miao, Y. Liu, X. Liu, Y. Zhang, W.
[5] For some examples, see: a) R. Y. Tsien, A. T. Harootunian, Cell Cal-
c) L. Xue, G. Li, Q. Liu, H. Wang, C. Liu, X. Ding, S. He, H. Jiang,
[6] a) V. T. Wieland, E. Bokelmann, L. Bauer, H. U. Lang, H. Lau,
Justus. Liebigs. Ann. Chem. 1953, 583, 129; b) M. Brenner, J. P. Zim-
mermann, J. Wehrmuller, P. Quitt, A. Hartmann, W. Schneider, U.
Berlinger, Helv. Chim. Acta 1957, 40, 1497; c) P. E. Dawson, T. W.
Muir, I. Clark-Lewis, S. B. H. Kent, Science 1994, 266, 776; d) Y.
Shin, K. A. Winans, B. J. Backes, S. B. H. Kent, J. A. Ellman, C. R.
Bertozzi, J. Am. Chem. Soc. 1999, 121, 11684.
d=1.31 (12H; CH3CH2), 3.58–3.93 (16H; CH3CH2 and N
ACHTNUGERTN(NUGN CH2CH2)2N),
6.71 (d, J=8.0 Hz, 2H; xanthene-H), 6.74 (s, 1H; coumarin-H), 6.85 (d,
À
À
J=8.0 Hz, 1H; Ar H), 6.95 (4H; xanthene-H and Ar H), 7.05 (s, 2H;
À
À
xanthene-H), 7.23 (2H; Ar H), 7.55 (d, J=8.5 Hz, 1H; Ar H), 7.63 (d,
J=6.0 Hz, 1H; coumarin-H), 8.00 (d, J=5.5 Hz, 1H; coumarin-H), 8.07
(s, 1H; coumarin-H), 8.41 ppm (s, 1H; Ar H); 13C NMR (CD3OD,
À
À
À
125 MHz): d=12.7 (CH3CH2), 46.8 (CH3CH2), 97.3 (Ar C), 103.3 (Ar
C), 112.3 (Ar C), 115. 1 (Ar C), 115.5 (Ar C), 116.2 (Ar C), 117.3
À
À
À
À
À
À
À
À
À
(Ar C), 120.1 (Ar C), 128.9 (Ar C), 131.6 (Ar C), 132.2 (Ar C), 132.3
À
À
À
À
À
(Ar C), 132.6 (Ar C), 133.6 (Ar C), 137.2 (Ar C), 138.9 (Ar C), 139.1
À
À
À
À
À
(Ar C), 145.8 (Ar C), 157.0 (Ar C), 157.5 (Ar C),157.6 (Ar C), 159.0
À
À
(Ar C), 160.5 (Ar C), 164.3 (C=O), 166.6 (C=O), 170.1 (C=O),
+
À
192.1 ppm (S C=O); ESI-MS: m/z: 851.2. [M] ; HRMS (ESI): m/z calcd
for: C49H47N4O8S1 [M]+: 851.3148; found: 851.3109; elemental analysis
calcd (%) for C49H47N4O8S+·H2PO4À·4H2O: C 57.64, H 5.63, N 5.49;
found: C 57.39, H 5.99, N 5.21. The presence of water molecules is con-
sistent with the hygroscopic nature of the compound.
Cell culture and living cell imaging studies with probe 1: HepG2 cells
were obtained from the third hospital of Xiangya and cultured in Dulbec-
co’s modified eagle medium (DMEM) supplemented with 10% fetal
bovine serum and 1% penicillin–streptomycin at 378C in a 5% CO2/
95% air environment. The cells were seeded on 12-well plates and stabi-
lized for 24 h. Before imaging, the cells were washed with PBS three
times and then incubated with probe 1 (3 mm) in PBS for 30 min under an
atmosphere of 5% CO2/95% air at 378C. For the control experiment, the
cells were pretreated with 1 mm NEM (or NAC or a-lipolic acid) for
60 min, and then incubated with probe 1 (3 mm) in PBS for 30 min in an
atmosphere of 5% CO2/95% air at 378C. After washing with PBS three
times to remove the remaining probe, the fluorescence images were ac-
quired using an Olympus fluorescence microscope equipped with
cooled CCD camera.
a
[8] For review and some examples, see: a) H. N. Kim, M. H. Lee, H. J.
Kim, J. S. Kim, J. Yoon, Chem. Soc. Rev. 2008, 37, 1465; b) Z. Zhou,
M. Yu, H. Yang, K. Huang, F. Li, T. Yi, C. Huang, Chem. Commun.
2008, 3387; c) A. Coskun, E. U. Akkaya, J. Am. Chem. Soc. 2006,
128, 14474; d) X. Zhang, Y. Xiao, X. Qian, Angew. Chem. 2008, 120,
8145; Angew. Chem. Int. Ed. 2008, 47, 8025; e) A. E. Albers, V. S.
Okreglak, C. J. Chang, J. Am. Chem. Soc. 2006, 128, 9640; f) C.
Kaewtong, J. Noiseephum, Y. Uppa, N. Morakot, N. Morakot, B.
Wanno, T. Tuntulani, B. Pulpoka, New J. Chem. 2010, 34, 1104; g) L.
Yuan, W. Lin, B. Chen, Y. Xie, Org. Lett. 2012, 14, 432; h) L. Yuan,
W. Lin, Y. Xie, B. Chen, J. Song, Chem. Commun. 2011, 47, 9372;
i) M. Suresh, S. Mishra, S. K. Mishra, E. Suresh, A. K. Mandal, A.
Shrivastav, A. Das, Org. Lett. 2009, 11, 2740; j) Y. Kurishita, T.
Kohira, A. Ojida, I. Hamachi, J. Am. Chem. Soc. 2010, 132, 13290;
k) L. Yuan, W. Lin, Y. Xie, B. Chen, J. Song, Chem. Eur. J. 2012, 18,
2700.
Acknowledgements
Funding was partially provided by NSFC (20872032, 20972044,
21172063), NCET (08–0175), the Doctoral Fund of Chinese Ministry of
Education (20100161110008), and the Fundamental Research Funds for
the Central Universities, Hunan University.
[1] a) R. O. Ball, G. Courtney-Martin, P. B. Pencharz, J. Nutr. 2006, 136,
1682S; b) R. Carmel, D. W. Jacobsen, Homocysteine in Health and
Disease, Cambridge University Press, Cambrigde (United Kingdom),
2001; c) P. J. Wlodek, M. B. Iciek, A. Milkowski, O. B. Smolenski,
Clin. Chim. Acta 2001, 304, 9; d) G. Bulaj, T. Kortemme, D. P. Gold-
enberg, Biochemistry 1998, 37, 8965; e) E. Weerapana, C. Wang,
G. M. Simon, F. Richter, S. Khare, M. B. D. Dillon, D. A. Bachov-
chin, K. Mowen, D. Baker, B. F. Cravatt, Nature 2010, 468, 790;
f) N. M. Giles, G. I. Giles, C. Jacob, Biochem. Biophys. Res.
Commun. 2003, 300, 1; g) K. G. Reddie, K. S. Carroll, Curr. Opin.
Chem. Biol. 2008, 12, 746; h) P. Nagy, C. C. Winterbourn, Adv. Mol.
Toxicol. 2010, 4, 183.
[10] The energy-transfer efficiency of the FRET dyad 1 was calculated
from the equation: E=100% [1-(fluorescence of donor in FRET
dyad)/(fluorescence of donor)]. J. R. Lakowicz, Principles of Fluo-
rescence Spectroscopy, 2nd ed., Kluwer/Plenum, New York, 1999.
[13] a) J. Shao, H. Sun, H. Guo, S. Ji, J. Zhao, W. Wu, X. Yuan, C.
Zhang, T. D. James, Chem. Sci. 2012, 3, 1049; b) D. Kand, A. M.
[2] a) S. Shahrokhian, Anal. Chem. 2001, 73, 5972; b) H. Refsum, P. M.
Ueland, O. Nygard, S. E. Vollset, Annu. Rev. Med. 1998, 49, 31;
c) W. G. Christen, U. A. Ajani, R. J. Glynn, C. H. Hennekens, Arch.
Intern. Med. 2000, 160, 422; d) M. T. Heafield, S. Fearn, G. B. Ste-
venson, R. H. Waring, A. C. Williams, S. G. Sturman, Neurosci. Lett.
1990, 110, 216; e) D. Lapenna, F. Cuccurullo, Gen. Pharmacol. 1996,
&
6
&
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 0000, 00, 0 – 0
ÝÝ
These are not the final page numbers!